• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Purpura

Purpura - 88 Studies Found

Completed : A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
: Idiopathic Thrombocytopenic Purpura
: 2008-10-09
:
  • Drug: rituximab Other Name: Ma

Active, not recruiting : The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
: Idiopathic Thrombocytopenic Purpura
: 2009-05-26
:
  • Drug: Dexamethasone Dexamethas

Terminated : A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
: Idiopathic Thrombocytopenic Purpura
: 2011-09-13
:
  • Drug: Eltrombopag Other Names:

Completed : Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
: Idiopathic Thrombocytopenic Purpura (ITP)
: 2009-03-10
: Drug: PG2 500mg/vial, iv infusion, 3 ~ 5 times/week, 2.5 ~ 3.5 hr/time
Recruiting : Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
: Chronic Idiopathic Thrombocytopenic Purpura
: 2015-11-19
: Drug: Hetrombopag Olamine
Completed : Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
: Idiopathic Thrombocytopenic Purpura (ITP)
: 2006-08-09
: Drug: IgNextGen 10% Ig NextGen 10% is a liquid formulation
Completed : Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
: Idiopathic Thrombocytopenic Purpura
: 2009-04-27
:
  • Drug: eltrombopag eltrombopag

Completed : Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
:
  • Idiopathic Thrombocytopenic Purpura
  • Immun
    : 2012-10-18
    : Biological: Inactivated Trivalent Influenza vaccine
Completed : Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
: Idiopathic Thrombocytopenic Purpura
: 2005-05-20
: Drug: AMG 531
Completed : Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
:
  • Chronic Idiopathic Thrombocytopenic Purpura
  • Purpura, Thrombocyt
    : 2007-02-27
    :
    • Drug: Placebo Placebo Tablets

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.